310 results about "Drug Containers" patented technology

An identification system and method for medication management comprises a controller, a drug library accessible by the controller, the drug library containing drug library profiles including a data set of drug information, and an identification module configured to read patient identification information from machine-readable identification devices worn by patients and to read drug information from machine-readable identification devices affixed to drugs or containers of drugs. The controller compares the read information to each other and to the drug library profile and provides alerts or error signals in the event of an inconsistency. In one case, identification devices are read by an optical reader fixedly mounted to the identification module. In another case, identification devices are read by an optical reader that is hand-held and mobile and can be moved to the location of the identification device. The hand-held reader communicates with the identification module by wired or wireless means. In another case, a third reader that is non-optical and wireless is fixedly mounted to the identification module. The controller is also configured to provide alerts or error messages in the event that there is an inconsistency between the drug information on the drug or drug container when compared to the drug library profile associated with the controller.

A nasal delivery device is provided for delivering substances such as liquid drugs, vaccines and the like to a nasal passage. The nasal delivery device preferably comprises a drug container such as syringe and a separable spray nozzle. The spray nozzle includes a rigid plastic cap having a spray aperture at a distal end of the nozzle for delivering the liquid substance to the nasal passage. Attachment means is provided for attaching the spray nozzle to the syringe at the time of the delivery of the liquid substance to the nasal passage. The nozzle defines a conduit that allows fluid communication from the syringe to the spray aperture. The nozzle includes an internal valve between the spray aperture and the syringe for allowing only pressurized liquid substance to flow through the conduit and the aperture so that a mist or spray is delivered through the spray aperture.

A self-contained illumination device for illuminating medicine container labels in low-light level conditions is provided. The illumination means includes a light source component for illumination, an electrical switch component to control the light source, supporting circuitry components to energize the light source, and a housing structure for supporting and enclosing the components, directing the illumination to the label, and coupling the illumination device to a medicine container receptacle or a conventional medicine container cap.

When using a drug container having an identification tag fixed or detachably provided at a predetermined position of the container, the tag having drug data on a kind and a concentration of a drug and both or one of upper and lower limits of a flow rate on a continuous infusion and the upper and lower limits, time and flow rate on a one-shot administration recorded thereon, it is possible to ensure safety by prompting for a stop of injection by a warning when a setting beyond the upper and lower limits is performed and rewrite a liquid infusing time and a flow rate and so on required to be set according to symptoms of a patient.

A container unit for a drug is composed of a container, which is formed of a cylindrical drug-solution-containing portion and a drug-solution-filling neck portion, and a rubber closure for sealing the drug-solution-filling neck portion. The rubber closure comprises a disk-shaped head portion and a substantially cylindrical leg portion arranged on a lower wall of the head portion. The container is provided with a flat surface formed on a side of its inner wall at a boundary between the drug-solution-containing portion and the drug-solution-filling neck portion such that a lower end wall of the leg portion of the rubber closure can be brought into close contact with the flat surface, and at least a side wall of the drug-solution-containing portion forms a cornerless, rounded surface on a side where a drug solution is to be contained. When the drug-solution-filling neck portion has been sealed with the rubber closure, the lower end wall of the leg portion and the flat surface of the container are maintained in close contact with each other without any protrusion of an inner circumferential edge of the lower end wall into an interior of the container beyond an inner circumferential edge of the flat surface.

A drug delivery device drive that includes a single shape memory alloy wire actuator to advance a lead screw via a ratcheting mechanism and method thereof are disclosed. In one embodiment, a shape memory alloy wire is operably connected to one of a pair of ratchet wheels and configured to drive incrementally the rotation of the connected ratchet wheel via a contraction, which in turn drives the rotation of the other ratchet wheel about a rotational axis which moves a lead screw and advances a plunger to dispense a liquid drug from a drug container. A drug delivery device using the shape memory alloy wire actuator in combination with the ratcheting mechanism to incrementally rotate a shaft, a lead screw or a sleeve provides for a more compact an less complicated design.

A device for storing and administering drug includes a housing, a sealing element (3) and a separate low friction plunger (4) which is substantially-permeable to gas over time. The sealing element (3) is typically broken to allow delivery of the drug. The housing (2) may be filled with the drug through an opening other than the opening through which the pusher (13) enters the housing to move the plunger so as to expel the drug during administration to a patient.